Analysts who follow Terns Pharmaceuticals Inc (TERN) on average expect it to gain 12.02% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns the stock an Analyst Ranking of 23, which means it ranks higher than 23 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating TERN a Buy today. Find out what this means to you and get the rest of the rankings on TERN!